28511906|t|Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin -based caps and o-phenylenediamine -based zinc binding groups
28511906|a|As a hot topic of epigenetic studies, histone deacetylases (HDACs) are related to lots of diseases, especially cancer. Further researches indicated that different HDAC isoforms played various roles in a wide range of tumor types. Herein a novel series of HDAC inhibitors with isatin -based caps and o-phenylenediamine -based zinc binding groups have been designed and synthesized through scaffold hopping strategy. Among these compounds, the most potent compound 9n exhibited similar if not better HDAC inhibition and antiproliferative activities against multiple tumor cell lines compared with the positive control entinostat (MS-275). Additionally, compared with MS-275 (IC50 values for HDAC1, 2 and 3 were 0.163, 0.396 and 0.605µM, respectively), compound 9n with IC50 values of 0.032, 0.256 and 0.311µM for HDAC1, 2 and 3 respectively, showed a moderate HDAC1 selectivity.
28511906	22	41	anti-tumor activity	T038	UMLS:C1148560
28511906	42	47	study	T062	UMLS:C2603343
28511906	57	87	histone deacetylase inhibitors	T103	UMLS:C1512474
28511906	99	105	isatin	T103	UMLS:C0022115
28511906	122	140	o-phenylenediamine	T103	UMLS:C0043796
28511906	186	204	epigenetic studies	T091	UMLS:C1655731
28511906	206	226	histone deacetylases	T103	UMLS:C0019643
28511906	228	233	HDACs	T103	UMLS:C0019643
28511906	258	266	diseases	T038	UMLS:C0012634
28511906	279	285	cancer	T038	UMLS:C0027651
28511906	295	305	researches	T062	UMLS:C0035168
28511906	331	344	HDAC isoforms	T103	UMLS:C0019643
28511906	423	438	HDAC inhibitors	T103	UMLS:C1512474
28511906	444	450	isatin	T103	UMLS:C0022115
28511906	467	485	o-phenylenediamine	T103	UMLS:C0043796
28511906	556	581	scaffold hopping strategy	T058	UMLS:C0022885
28511906	595	604	compounds	T103	UMLS:C1706082
28511906	622	633	compound 9n	T103	UMLS:C1706082
28511906	666	670	HDAC	T103	UMLS:C0019643
28511906	671	681	inhibition	T038	UMLS:C1524081
28511906	686	714	antiproliferative activities	T038	UMLS:C1148560
28511906	732	748	tumor cell lines	T017	UMLS:C0085983
28511906	784	794	entinostat	T103	UMLS:C2743752
28511906	796	802	MS-275	T103	UMLS:C1510480
28511906	833	839	MS-275	T103	UMLS:C1510480
28511906	857	862	HDAC1	T103	UMLS:C2718309
28511906	864	865	2	T103	UMLS:C0768528
28511906	870	871	3	T103	UMLS:C1098658
28511906	918	929	compound 9n	T103	UMLS:C1706082
28511906	979	984	HDAC1	T103	UMLS:C2718309
28511906	986	987	2	T103	UMLS:C0768528
28511906	992	993	3	T103	UMLS:C1098658
28511906	1026	1031	HDAC1	T103	UMLS:C2718309